Monographie - Morphine tartrate - Stabilis 4.0

Ultimo aggiornamento :
19/11/2024

Antalgico

Morphine tartrate

Iniezione

Stabilità in soluzione

Stabilità in miscela

Fattori che influenzano la stabilità

Compatibilità

metodo di iniezione

Bibliografia

pdf

Struttura chimica

Nome commerciale

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Morphine tartrate

Australia

Bibliografia

Iniezione

Bibliografia : Morphine tartrate

	tipo	pubblicazione
519	Rivista	Poggi GL. Compatibility of morphine tartrate admixtures in polypropylene syringes. Aust J Hosp Pharm 1991 ; 21: 316.
920	Rivista	Targett PL, Keefe PA, Merridew CG. Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes. Aust J Hosp Pharm 1997 ; 27: 452-454.
980	Rivista	Ambados F. Compatibility of morphine and ketamine for subcutaneous infusion. Aust J Hosp Pharm 1995 ; 25: 352.
1864	Rivista	Lau MH, Hackman C, Morgan DJ. Compatibility of ketamine and morphin injections. Pain 1998 ; 75: 389-390.
2083	Rivista	La Forgia SP, Sharley NA, Burgess NG, Doecke CJ. Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion. J Pharm Pract and Res 2002 ; 32: 65-68.
3474	Laboratorio	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3504	Laboratorio	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012
3644	Laboratorio	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3675	Laboratorio	Thiopental sodium - Summary of Product Characteristics Archimedes Pharma UK Ltd 2015
3838	Laboratorio	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3934	Laboratorio	Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit GlaxoSmithKline Laboratoire 2016

Mentions Légales